Richard Scott Huennekens
Lead Independent DirectorMr. Richard Scott Huennekens, CPA, M.B.A., has been the Director at DeepSight Technology, Inc. since October 2026. He is Director of Endologix LLC from July 2025. Mr. Huennekens is Independent Director of NeuroPace, Inc. from January 6, 2025. He is Independent Director of QuidelOrtho Corporation from December 6, 2024. Mr. Huennekens is a successful MedTech CEO, Chair, board member, entrepreneur and investor and has been involved in over 20 startups and public companies. Mr. Huennekens was the Member of the Advisory Board of Peloton Equity, LLC. He is Member of Advisory Board of Peloton Equity, LLC. He is Director of EndoChoice, Inc. He joined the EndoChoice, Inc. in January 2014. He is Executive Chairperson of On Target Laboratories, Inc. He is Executive Chairman of the Board of Elucid Bioimaging Inc. from April 2023. He is Independent Director of Foldax, Inc. from January 2022. He is Advisor of Proximie Inc. from February 2021. He is Director of Q'Apel Medical, Inc. He was Independent Chairman of the Board of Envista Holdings Corporation from September 20, 2019 until August 19, 2026 and is its Lead Independent Director from August 19, 2026. He was Member of Advisory Council of BrightInsight, Inc. from September 2022 until April 2026. He is Chairman of VIDA FLaSH Acquisitions from January 29, 2021. He served as Director of Veranex, Inc. He was Executive Chairman of Hyperfine, Inc. from October 24, 2022 to May 22, 2025. He was Executive Chairman, Interim President & CEO of Hyperfine, Inc. from July 29, 2022 to October 24, 2022. He was Executive Chairman of Hyperfine, Inc. from April 2021 to July 29, 2022. He was Independent Director of ViewRay, Inc. from February 07, 2018 to June 11, 2021. He was employed at ViewRay, Inc. from February 07, 2018 to June 11, 2021. He was Director Nominee of Asensus Surgical, Inc. He was Director of EndoChoice Holdings, Inc. He was employed at EndoChoice Holdings, Inc. from April 2013 to November 22, 2016. He was Independent Director of NuVasive, Inc. from October 01, 2018. He was Non-Executive Director of REVA Medical, Inc. from March 25, 2015 to May 17, 2018. He was employed at REVA Medical, Inc. from March 25, 2015 to May 17, 2018. He was President and Director of Star Equity Holdings, Inc. He joined the Star Equity Holdings, Inc. in May 1999. Mr. Huennekens served as President, Chief Executive Officer and Chairman of Verb Surgical Inc., a surgical robotics company. From March 2002 until its sale to Royal Phillips NV in June 2015, He was Independent Director of Bellerophon Therapeutics, Inc. He was employed at Bellerophon Therapeutics, Inc. from May 2015 to December 01, 2015. He was Director of Volcano Corporation. He joined the Volcano Corporation in April 2002. He was Director of Uptake Medical Technology, Inc. He joined the Uptake Medical Technology, Inc. on March 01, 2011. He was Chief Executive Officer of Volcano and President of Volcano of Lumen Biomedical, Inc. He was employed at Lumen Biomedical, Inc. until October 21, 2016. He was Executive Chairman of Acutus Medical, Inc. from July 10, 2019 to January 15, 2024. He was employed at Acutus Medical, Inc. until January 15, 2024. He was Director of Sonendo, Inc. He has M.B.A. from Harvard Business School, B.S.B.A. from University of Southern California in 1986, B.S.B.A. from University of California.
Positions
- Company NameEnvista Holdings CorporationStock CodeNVSTPositionLead Independent DirectorColleagues
- PAPaul A. KeelPresident, CEO & Chairman
- EDEric D. HammesSenior VP & CFO
- MEMark E. NanceSenior VP, General Counsel & Secretary
- RBRobert BefidiSenior VP & President of Diagnostics
- VAVeronica AcurioSenior VP & President of Orthodontics
- WCWendy CarruthersIndependent Director
- CAChristine A. TsingosIndependent Director
- KTKieran T. GallahueIndependent Director
- Company NameNeuroPace, Inc.Stock CodeNPCEPositionIndependent DirectorColleagues
- JDJoel D. BeckerCEO, President & Director
- FMFrank M. FischerChairman of the Board
- PFPatrick F. WilliamsChief Financial Officer
- MJMartha J. MorrellChief Medical Officer
- DSDylan St. JohnChief of Operations & Development
- SRScott R. SchaperVice President of Finance & Investor Relations
- RKRakhi KumarIndependent Director
- LMLisa M. AndradeIndependent Director
- RSRichard Scott HuennekensIndependent Director
